Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel

por Oikonomopoulou, K, Li, L, Zheng, Y, Simon, I, Wolfert, R L, Valik, D, Nekulova, M, Simickova, M, Frgala, T, Diamandis, E P
Publicado 2008

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma

por Fens, M H A M, Hill, K J, Issa, J, Ashton, S E, Westwood, F R, Blakey, D C, Storm, G, Ryan, A J, Schiffelers, R M
Publicado 2008

CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype

por Helsby, N A, Lo, W-Y, Sharples, K, Riley, G, Murray, M, Spells, K, Dzhelai, M, Simpson, A, Findlay, M
Publicado 2008

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

por Catalano, V, Graziano, F, Santini, D, D'Emidio, S, Baldelli, A M, Rossi, D, Vincenzi, B, Giordani, P, Alessandroni, P, Testa, E, Tonini, G, Catalano, G
Publicado 2008

Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival i...

por Mathew, P, Thall, P F, Wen, S, Bucana, C, Jones, D, Horne, E, Oh, W K, Morris, M J, Lee, Y-C, Logothetis, C J, Lin, S-H, Fidler, I J
Publicado 2008

Overexpression of β2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion

por Chen, C-H, Su, C-Y, Chien, C-Y, Huang, C-C, Chuang, H-C, Fang, F-M, Huang, H-Y, Chen, C-M, Chiou, S-J
Publicado 2008

Cell cycle times of short-term cultures of brain cancers as predictors of survival

por Furneaux, C E, Marshall, E S, Yeoh, K, Monteith, S J, Mews, P J, Sansur, C A, Oskouian, R J, Sharples, K J, Baguley, B C
Publicado 2008

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

por McKiernan, E, O'Brien, K, Grebenchtchikov, N, Geurts-Moespot, A, Sieuwerts, A M, Martens, J W M, Magdolen, V, Evoy, D, McDermott, E, Crown, J, Sweep, F C G J, Duffy, M J
Publicado 2008

Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs

por Ridolfi, E, Matteucci, E, Maroni, P, Desiderio, M A
Publicado 2008

Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors

por Diallo, J-S, Betton, B, Parent, N, Péant, B, Lessard, L, Le Page, C, Bertrand, R, Mes-Masson, A-M, Saad, F
Publicado 2008

Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells

por Benhadji, K A, Serova, M, Ghoul, A, Cvitkovic, E, Le Tourneau, C, Ogbourne, S M, Lokiec, F, Calvo, F, Hammel, P, Faivre, S, Raymond, E
Publicado 2008

2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer

por Tagg, S L C, Foster, P A, Leese, M P, Potter, B V L, Reed, M J, Purohit, A, Newman, S P
Publicado 2008

Radon and risk of extrapulmonary cancers: results of the German uranium miners' cohort study, 1960–2003

por Kreuzer, M, Walsh, L, Schnelzer, M, Tschense, A, Grosche, B
Publicado 2008

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

por Koutras, A K, Kalogeras, K T, Dimopoulos, M-A, Wirtz, R M, Dafni, U, Briasoulis, E, Pectasides, D, Gogas, H, Christodoulou, C, Aravantinos, G, Zografos, G, Timotheadou, E, Papakostas, P, Linardou, H, Razis, E, Economopoulos, T, Kalofonos, H P, Fountzilas, G
Publicado 2008

Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells

por Singh, R K, Lange, T S, Kim, K K, Singh, A P, Vorsa, N, Brard, L
Publicado 2008

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

por McKeage, M J, Von Pawel, J, Reck, M, Jameson, M B, Rosenthal, M A, Sullivan, R, Gibbs, D, Mainwaring, P N, Serke, M, Lafitte, J-J, Chouaid, C, Freitag, L, Quoix, E
Publicado 2008

Population screening for colorectal cancer: the implications of an ageing population

por Macafee, D A L, Waller, M, Whynes, D K, Moss, S, Scholefield, J H
Publicado 2008

Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: Report from the National Cancer Research Institute (NCRI) Teenage...

por Fern, L, Davies, S, Eden, T, Feltbower, R, Grant, R, Hawkins, M, Lewis, I, Loucaides, E, Rowntree, C, Stenning, S, Whelan, J
Publicado 2008

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast

por Millar, E K A, Anderson, L R, McNeil, C M, O'Toole, S A, Pinese, M, Crea, P, Morey, A L, Biankin, A V, Henshall, S M, Musgrove, E A, Sutherland, R L, Butt, A J
Publicado 2009

Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin

por Wu, X, Wanders, A, Wardega, P, Tinge, B, Gedda, L, Bergstrom, S, Sooman, L, Gullbo, J, Bergqvist, M, Hesselius, P, Lennartsson, J, Ekman, S
Publicado 2009